Vermillion to Participate in Statewide Women and Girls Day at the Connecticut State Capital on March 6, 2020 – Yahoo Finance

Posted: March 4, 2020 at 6:46 pm

AUSTIN, Texas, March 04, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based womens health company focused on gynecologic disease, today announced Valerie Palmieri will participate on a Women in Leadership Panel, representing the corporate sector, at Women and Girls Day at the Connecticut State Capital. The all-day event is in celebration of Womens History Month and the 100thanniversary of womens suffrage. The company will also have an education booth on site for OVA1 Plus and overall Ovarian Cancer Awareness.

The event, hosted by the State of Connecticut, will be moderated by Melissa McCaw, Secretary of the Office of Policy and Management for the State of Connecticut and will feature topics critical to womens health. Other participants in the panel include: Susan Bysiewicz, Lieutenant Governor for the State of Connecticut; Dr. Elsa Nez, President of Eastern Connecticut State University; and Fran Pastore, CEO and Founder of Womens Business Development Council.

We are very honored to participate in this prestigious event and to be recognized by the Governor and Lt. Governor from the State of Connecticut for our commitment to womens health, said Valerie Palmieri, CEO of Vermillion, Inc.

About Vermillion, Inc.Vermillion, Inc. is transforming womens health with the discovery, development and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1plus combines our FDA-cleared products OVA1 and OVERA to detect risk of ovarian malignancy in women with adnexal masses. Recently launched, ASPiRA GenetiXSM testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment Vermillion has expertise in cutting-edge research to inform our next generation of products. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection and optimize treatment plans. Visit our website for more information about our products at http://www.vermillion.com.

Investor Relations Contact:Ashley R. RobinsonLifeSci Advisors, LLCTel 617-775-5956Arr@LifeSciAdvisors.com

The rest is here:
Vermillion to Participate in Statewide Women and Girls Day at the Connecticut State Capital on March 6, 2020 - Yahoo Finance

Related Posts

Comments are closed.

Archives